We’re seeing much the same approach to monetary policy around the world. The Reserve Bank of New Zealand (RBNZ), which has been threatening to go “full Switzerland” and start intervening in the FX market along with negative rates, briefed reporters on their possible additional policy measures. They made it clear that they’re preparing to do more. “We have a least regrets approach to thinking how much stimulus to deliver,” RBNZ Chief Economist Yuong Ha said. “We’d rather do too much too soon than too little too late.”

We heard the same line Tuesday from Fed Chair Powell. “At this early stage, I would argue that the risks of policy intervention are still asymmetric. Too little support would lead to a weak recovery…By contrast, the risks of overdoing it seem, for now, to be smaller.”

That statement can help us to understand one of the key lines in the minutes from the September meeting of the Federal Open Market Committee (FOMC), the US central bank’s rate-setting policy board. The minutes said, “many participants noted that their economic outlook assumed additional fiscal support and that if future fiscal support was significantly smaller or arrived significantly later than they expected, the pace of the recovery could be slower than anticipated.

The phrase “significantly later than expected” is important, as it indicates the Fed views stimulus now as qualitatively different than stimulus in three months, when former VP Joe Biden will (we assume) be president. “The pace of economic improvement has moderated since the outsize gains of May and June,” Powell noted. “…a prolonged slowing in the pace of improvement over time could trigger typical recessionary dynamics, as weakness feeds on weakness.” Weak demand triggers bankruptcies and job losses, which causes demand to weaken

Week In Review

  • The Wall Street Journal pointed out this Monday that China has steadily increased its purchases of US crude oil since May.
  • Bloomberg announced this Tuesday that Singaporean sovereign wealth funds, GIC and Temasek will participate in the Ant Group IPO, with the former reportedly making a $1 billion investment.
  • It was reported this Wednesday that over 400 million Chinese are vacationing domestically during the Golden Week holiday. Thus, it is no surprise that consumption plays are performing well this week.
  • On Thursday, Ping An Insurance-backed company Lufax Holdings filed for a New York Stock Exchange listing under the ticker LU.

Key News

Let’s not bury the lead: THE STRONGEST SINGLE DAY OF PERFORMANCE FOR THE RENMINBI VERSUS THE US DOLLAR IN 15 YEARS! The renminbi (RMB) moved $0.09 versus the USD last night! You might remember how China “devalued” its currency back in August 2015. Last night’s move was almost the same magnitude as 2015, but the other way around! Regardless, back then the headlines SCREAMED about the “devaluation” for weeks. Don’t get me wrong, Summer 2015 was awful as China’s Mainland stock market fell and then the currency drop left a Grand Canyon-sized wrinkle in between my eyebrows. However, with such a strong move to the upside, I would have expected at least a few headlines covering the RMB’s historic positive move last night… (For my friends in Europe & UK, the appreciation wasn’t as pronounced versus the Euro or Pound.)

While I have your attention, I will point out the growing disparity between MSCI’s
MSCI
definition of Chinese A-Shares and domestic indices such as the CSI 300. MSCI added mid-cap stocks to its definition of A-Shares in November 2019. My colleagues and I have been pounding the table about how the mid-caps gave MSCI’s

Oct 7 (Reuters)The Australian dollar has recouped some of Tuesday’s 1.1% losses that were largely driven by broad USD gains amid a rise in risk aversion, but was the dip a buying opportunity or more likely, the start of a deeper decline?

The risk selloff was prompted by President Trump’s decision to end coronavirus stimulus negotiations even as Federal Reserve Chairman Powell expressed fears of the economic recovery stalling .

There is every chance that the breakdown in negotiations will take time to be fully priced in, which will increase uncertainty, and should support the safe-haven USD, while the AUD was already heavy on market expectations that the RBA may ease policy in November .

AUD/USD is closer to the top of its 0.5510-0.7413 2020 range, as is the trade-weighted index =AUD at 61.10, in a 49.90-62.90 2020 range, so the AUD is strong at these levels.

Morgan Stanley’s Oct 5 FX Position Tracker suggested AUD positioning was neutral. The combination of a resilient USD on global growth uncertainty ahead of RBA easing and neutral positioning makes the AUD/USD a sell-on-rallies. A move towards 0.7150, with stops above the October double top and 50% of the September fall at 0.7210, would be an opportunity, looking for a test and possible break of the 0.7006 September low.

For more click on FXBUZ

aud 2 oct 7https://tmsnrt.rs/30D6iMk

(Andrew Spencer is a Reuters market analyst. The views expressed are his own)

((Andrew.m.spencer@thomsonreuters.com))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source Article

Zion Market Researchhas published a new report titled “Healthcare Insurance Market by Provider (Private Providers and Public Providers), by Product (Disease Insurance, Medical Insurance, and Income Protection Insurance), by Provider Network (Preferred Provider Organizations (PPOs), Point Of Service (POS), Health Maintenance Organizations (HMOs), and Exclusive Provider Organizations (EPOs)), by Type (Lifetime Coverage and Term Coverage), and by Demographics (Minors, Adults, and Senior Citizens): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2026”. According to the report, the globalhealthcare insurance marketwas valued at approximately USD 1,010.3 billion in 2017 and is expected to generate revenue of around USD 2,030.1 billion by the end of 2026, growing at a CAGR of around 7.9% between 2018 and 2026.

Medical spending makes poor often vulnerable and results in huge amounts of household spending. Health insurance eliminates or reduces out-of-pocket spending on healthcare solutions and ensures financial risk protection. Government plays a prominent role in deciding the healthcare policies of a country, which directly affects the development of the healthcare insurance market. Supportive government policies is invading the prominent growth of healthcare insurance market, whereas, affordable access to quality treatment and essential medicines depends on several factors, such as provision and use of medicines, sound policies on selection and pricing, efficient regulation by the government and ruling authorities, functioning health infrastructure, a qualified health workforce, good governance, and information systems. Most of the low- and middle-income countries struggle to meet these criteria and fail to provide prominent healthcare services to their population.

Get PDF Sample Copy of this Report to understand the structure of the complete report @https://www.zionmarketresearch.com/sample/healthcare-insurance-market/news

However, the GDP growth has accelerated the expansion of the healthcare insurance market. Healthcare insurance companies are growing mainly due to the emergence of the middle class, rising disposable income, and increasing per capita income globally. The

Newark, NJ, Sept. 30, 2020 (GLOBE NEWSWIRE) — As per the report published by Fior Markets, the global health insurance market is expected to grow from USD 1465.8 billion in 2019 and to reach USD 2021.62 billion by 2027, growing at a CAGR of 4.7% during the forecast period 2020-2027.

The global health insurance market is witnessing significant growth from recent years. This growth is attributed to the increasing geriatric population, high medical costs, government initiatives for developing reimbursement policies for surgical procedures, and the need for an efficient flow of processes without any inconvenience caused due to the payment process. The increased cost of healthcare services and the high prevalence of lifestyle diseases will propel the market growth.

Health insurance is referred to as insurance that covers medical expenses that arise due to illness. These medical expenses can be related to hospitalization costs, cost of medicines or doctor consultation fees. It offers flexibility in disease or ailment coverage. For the estimation of overall risk of health and health system expenses, an insurer develops a regular finance structure like payroll tax or monthly premium, to provide money to pay for healthcare benefits that are specified in the insurance agreement. Health insurance policy is often included in employer benefit package as a means of enticing quality employees. 

The global health insurance market is expected to witness significant growth, owing to the mandatory provisions of health insurance to the public and private sector, and increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases. The factors restraining the market growth are the exclusion of various expensive medical treatments from the policy and increased cost of healthcare insurance products. The introduction of advanced and innovative technology in health settings will provide market growth opportunities.

DOWNLOAD FREE SAMPLE REPORT AT https://www.fiormarkets.com/report-detail/418897/request-sample

The key